Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Dr. Bruce Hamory

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman

Oliver Wyman research highlights key treatment decision and prevalence of avoidable care.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Global Head, Health Services, Oliver Wyman

Why is the shift to value taking so long? And where are the promised results? There's nothing wrong with the model; the problem is in execution and implementation.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman

Understanding clinical variation is key to identifying inappropriate care; addressing inappropriate care is key to reducing costs and improving quality.

Global Head, Health Services, Oliver Wyman
Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman

As provider organizations prepare for MACRA, they should consider these five workforce and organizational issues.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman

A comprehensive view of the ACO market, including a detailed look at “winners”, regional differences, and success rates by type.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Associate, Oliver Wyman

Insights in your inbox

Subscribe

Oliver Wyman analysis details the performance of ACOs by type (physician-led, hospital-led, commercial) and offers insight into what it will take for each to be successful.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Although the details and timing of repeal-and-replace are as yet unknown, providers can still begin preparing for change.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman

Why the path to value remains necessary to offset the high-cost/low-quality formula – no matter who is sitting in the White House.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Global Head, Provider, Health & Life Sciences, Oliver Wyman

Oliver Wyman's Chief Medical Officer breaks down how healthcare providers may be impacted by an ACA repeal.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman

Our Chief Medical Officer Dr. Bruce Hamory charts the progress of federal value-based initiatives, pilots, and targets.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe